was read the article
array:22 [ "pii" => "S1665268124002084" "issn" => "16652681" "doi" => "10.1016/j.aohep.2024.101414" "estado" => "S300" "fechaPublicacion" => "2024-02-01" "aid" => "101292.27" "copyrightAnyo" => "2024" "documento" => "simple-article" "crossmark" => 0 "subdocumento" => "abs" "cita" => "Ann Hepatol. 2024;29 Supl 2:" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "itemSiguiente" => array:17 [ "pii" => "S1665268124002096" "issn" => "16652681" "doi" => "10.1016/j.aohep.2024.101415" "estado" => "S300" "fechaPublicacion" => "2024-02-01" "aid" => "101292.28" "documento" => "simple-article" "crossmark" => 0 "subdocumento" => "abs" "cita" => "Ann Hepatol. 2024;29 Supl 2:" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:9 [ "idiomaDefecto" => true "titulo" => "Extrahepatic disease in a cohort of HCV infected patients succesfully treated with direct acting antivirals. One year follow up." "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => "en" "contieneResumen" => array:1 [ "en" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Clara C. Sánchez-Rodríguez, Jorge H. Luna-Domínguez" "autores" => array:2 [ 0 => array:2 [ "nombre" => "Clara C." "apellidos" => "Sánchez-Rodríguez" ] 1 => array:2 [ "nombre" => "Jorge H." "apellidos" => "Luna-Domínguez" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1665268124002096?idApp=UINPBA00004N" "url" => "/16652681/00000029000000S2/v2_202404250742/S1665268124002096/v2_202404250742/en/main.assets" ] "itemAnterior" => array:17 [ "pii" => "S1665268124002072" "issn" => "16652681" "doi" => "10.1016/j.aohep.2024.101413" "estado" => "S300" "fechaPublicacion" => "2024-02-01" "aid" => "101292.26" "documento" => "simple-article" "crossmark" => 0 "subdocumento" => "abs" "cita" => "Ann Hepatol. 2024;29 Supl 2:" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:9 [ "idiomaDefecto" => true "titulo" => "Epidemiology and demographic aspects in patients with acute on chronic liver failure in a third-level care hospital in Mexico." "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => "en" "contieneResumen" => array:1 [ "en" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Guadalupe Zafra-Hernandez, Alejandro Meneses-Parga, Jesus R. Hernandez-Maya, Rosalba Moreno-Alcantar, Ricardo Sandoval-Salas" "autores" => array:5 [ 0 => array:2 [ "nombre" => "Guadalupe" "apellidos" => "Zafra-Hernandez" ] 1 => array:2 [ "nombre" => "Alejandro" "apellidos" => "Meneses-Parga" ] 2 => array:2 [ "nombre" => "Jesus R." "apellidos" => "Hernandez-Maya" ] 3 => array:2 [ "nombre" => "Rosalba" "apellidos" => "Moreno-Alcantar" ] 4 => array:2 [ "nombre" => "Ricardo" "apellidos" => "Sandoval-Salas" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1665268124002072?idApp=UINPBA00004N" "url" => "/16652681/00000029000000S2/v2_202404250742/S1665268124002072/v2_202404250742/en/main.assets" ] "en" => array:10 [ "idiomaDefecto" => true "titulo" => "CLIF-C-ACLF scale to predict mortality in pediatric patients with acute-on-chronic liver failure" "tieneTextoCompleto" => true "autores" => array:1 [ 0 => array:3 [ "autoresLista" => "Diego R. Arellano-Sánchez, Elizabeth Hernández-Chávez" "autores" => array:2 [ 0 => array:2 [ "nombre" => "Diego R." "apellidos" => "Arellano-Sánchez" ] 1 => array:2 [ "nombre" => "Elizabeth" "apellidos" => "Hernández-Chávez" ] ] "afiliaciones" => array:1 [ 0 => array:2 [ "entidad" => "Pediatric Gastroenterology and Nutrition Service, UMAE Pediatric Hospital, Western National Medical Center, IMSS, Guadalajara Jalisco, Mexico" "identificador" => "aff0001" ] ] ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="para0005" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">Ethical statement</span></p><p id="para0006" class="elsevierStylePara elsevierViewall">The protocol was registered and approved by the Ethics Committee. The identity of the patients is protected. Consentment was obtained.</p><p id="para0007" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">Declaration of interests</span></p><p id="para0008" class="elsevierStylePara elsevierViewall">None</p><p id="para0009" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">Funding</span></p><p id="para0010" class="elsevierStylePara elsevierViewall">This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.</p><p id="para0011" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">AUROC of CLIF-C ACLF, MELD/PELD, Child Pugh, AARC in predicting at admission, 28- and 90 - days mortality.</span><elsevierMultimedia ident="fig0001"></elsevierMultimedia></p></span>" "pdfFichero" => "main.pdf" "tienePdf" => true "tieneResumen" => true "resumen" => array:1 [ "en" => array:2 [ "resumen" => "<span id="abss0001" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="cesectitle0001">Introduction and Objectives</span><p id="spara001" class="elsevierStyleSimplePara elsevierViewall">The acute decompensation of liver cirrhosis associated with organ failure is known as acute-on-chronic liver failure (ACLF); in pediatrics, it develops >22%, with mortality >33% per month; Based on prognosis, CLIF-C ACLF is a score with greater discriminative capacity to predict short-term mortality (25%) compared to already established scales, which require more complex variables. To describe the utility of the CLIF-C ACLF scale in pediatrics. Specific: In children with cirrhosis who developed ACLF: Describe the sociodemographic, clinical, and biochemical characteristics; Determine the MELD, PELD, Child Pugh, AARC and CLIF-C ACLF scales and compare their predictive value.</p></span> <span id="abss0002" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="cesectitle0002">Materials and Patients</span><p id="spara002" class="elsevierStyleSimplePara elsevierViewall">Retrospective cohort, age: 6 months to 18 years, temporality: March 2018 - February 2022. Frequency and percentage were reported for qualitative variables, and median variables and range for quantitative variables; Inferential with Pearson and Spearman correlation between the scales at admission, 28 and 90 days, an area under the receiver operating characteristics (AUROC) and Whitney U were calculated.</p></span> <span id="abss0003" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="cesectitle0003">Results</span><p id="spara003" class="elsevierStyleSimplePara elsevierViewall">Out of 95 cases with chronic liver disease, 63.1% presented ACLF, mostly stage II (35.3%). The female sex predominated (72.1%) and bile duct atresia was the most common entity (80%), with a mean age at diagnosis of 38 months and mortality of 55%. Ascites (97%) and hepatic encephalopathy (58.3%) were the main complications. The major precipitating factors described were infections (57.4%): bacterial cholangitis (16.2%) and pneumonia (8.8%). Through AUROC we compared CLIF cACLF with PELD, MELD, Child Pugh and AARC, observing greater statistical significance at 28 and 90 days (sensitivity: 0.63, specificity: 0.85) and through the U test, we observed that coagulopathy is the biochemical index with higher prediction for acute decompensation in ACLF.</p></span> <span id="abss0004" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="cesectitle0004">Conclusions</span><p id="spara004" class="elsevierStyleSimplePara elsevierViewall">CLIF-C ACLF compared to ACLF scores predicted increased risk of 28-day mortality (AUROC: 0.758) relative to PELD, MELD (AUROC: 0.721), Child Pugh (AUROC: 0.746), AARC (AUROC: 0.621), and at 90 days (AUROC: 0.663) with PELD, MELD (AUROC: 0.505), Child Pugh (AUROC: 0.598), AARC (AUROC: 0.357). We established a CLIF-C ACLF score ≥ 77.5 as a high predictor of mortality (95% CI). The scale is useful in pediatrics.</p></span>" "secciones" => array:4 [ 0 => array:2 [ "identificador" => "abss0001" "titulo" => "Introduction and Objectives" ] 1 => array:2 [ "identificador" => "abss0002" "titulo" => "Materials and Patients" ] 2 => array:2 [ "identificador" => "abss0003" "titulo" => "Results" ] 3 => array:2 [ "identificador" => "abss0004" "titulo" => "Conclusions" ] ] ] ] "multimedia" => array:1 [ 0 => array:6 [ "identificador" => "fig0001" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => false "mostrarDisplay" => true "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr17.jpeg" "Alto" => 2071 "Ancho" => 1500 "Tamanyo" => 280184 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "alt0001" "detalle" => "Unlabelled imag" "rol" => "short" ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/16652681/00000029000000S2/v2_202404250742/S1665268124002084/v2_202404250742/en/main.assets" "Apartado" => null "PDF" => "https://static.elsevier.es/multimedia/16652681/00000029000000S2/v2_202404250742/S1665268124002084/v2_202404250742/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1665268124002084?idApp=UINPBA00004N" ]
Year/Month | Html | Total | |
---|---|---|---|
2024 November | 4 | 0 | 4 |
2024 October | 17 | 4 | 21 |
2024 September | 21 | 10 | 31 |
2024 August | 20 | 14 | 34 |
2024 July | 18 | 14 | 32 |
2024 June | 31 | 10 | 41 |
2024 May | 23 | 6 | 29 |
2024 April | 24 | 13 | 37 |
2024 March | 18 | 15 | 33 |